Biotech | July 31, 2025
Fortis and Agilus expand rapid genomic testing capabilities
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Upgrades 2025 full-year CDMO sales and margin outlook
Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
Subscribe To Our Newsletter & Stay Updated
